(1 - 16 von 21
)
Seagen - Seattle Genetics and Astellas Announce Submission of...
investor.seagen.com
16, Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., “Astellas”) ...
Astellas Announces Acquisition of Quethera
www.prnewswire.co.uk
PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa,Ph.D., "Astellas") and Quethera Limited (CEO: Peter ...
Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the...
investor.fibrogen.com
(TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., "Astellas") and FibroGen, Inc. (Nasdaq: FGEN, CEO: Enrique Conterno , " FibroGen ...
Astellas Receives U.S. FDA Fast Track Designation for ASP5354, an...
newsroom.astellas.us
(TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas" ) announced today that the United States ("U.S.") Food and Drug ...
sortiert nach Relevanz / Datum